Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

Clinical trial NCT04042753 · COMPLETED

Trial details

NCT number: NCT04042753
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pituitary Pituitary Tumor Pituitary Carcinoma Pituitary Cancer

Start date: 2019-07-31
Primary completion: 2026-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.